BPC-157: Compound Profile, Structure and Regulation
A chemical profile of BPC-157: the 15-residue sequence and its identifiers, salt forms, how identity is checked in the laboratory, storage, and its place in the Australian Poisons Standard.
CATALOGUE / BPC-157
Research peptide · Lyophilised powder in a sealed vial · for laboratory and research use only
| CAS number | 137525-51-0 |
|---|---|
| Molecular weight | 1419.5 g/mol (free peptide; PubChem reference value) |
| Storage | Sealed, dry and dark at −20 °C or colder; −50 to −80 °C for long-term storage |
| Certificate of analysis | Available on request · Request a COA |
CAS number and molecular weight are reference values for the compound identity, from PubChem. Salt forms, such as a trifluoroacetate, have a different formula and mass.
| Compound class | Synthetic linear peptide (pentadecapeptide, 15 residues) |
|---|---|
| Sequence (one-letter) | GEPPPGKPADDAGLV |
| Sequence (three-letter) | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular formula | C62H98N16O22 (free peptide, PubChem) |
| PubChem CID | 9941957 |
| Other names | PL 14736, PLD-116, PL-10, bepecin |
| Supplied as | Lyophilised powder, sealed vial |
| Quantity per vial | 10 mg |
| Intended use | Laboratory and research use only |
BPC-157 is a synthetic pentadecapeptide, a linear chain of 15 amino acids with the sequence GEPPPGKPADDAGLV.1 It was first described in 1993 by researchers at the University of Zagreb as a partial sequence of a larger protein they reported in gastric juice. Research material is made by solid-phase peptide synthesis, not extracted.
Titan Peptides supplies BPC-157 as a lyophilised powder in a sealed 10 mg vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.
In Australia, BPC-157 is listed in Schedule 4 (Prescription Only Medicine) of the Poisons Standard June 2026 (F2026L00633) and in Appendix D, clause 5, which lists poisons that must not be possessed without authority.2 The TGA's safety advisory of 13 April 2026 names BPC-157 as an example of an unapproved peptide product and states that a "research use only" disclaimer does not make its supply lawful.3
BPC-157 is not an approved therapeutic good in Australia; the vial sold here is a research chemical. Our guide to research peptides and Australian law explains how scheduling applies.
Keep the sealed vial dry, dark and frozen at −20 °C or colder, and colder still (−50 to −80 °C) for long-term storage. Let it reach room temperature in a desiccator before opening, so moisture does not condense on the hygroscopic powder. The sequence has none of the cysteine, methionine or tryptophan residues most prone to oxidation, nor the asparagine or glutamine residues prone to deamidation, but solutions are still short-lived: split a reconstituted stock into single-use aliquots, freeze them, and discard a thawed aliquot rather than refreezing it. See how to store peptides and reconstituting peptides with bacteriostatic or sterile water for the reasoning behind each step.
BPC-157 is supplied as a lyophilised (freeze-dried) powder in a sealed vial containing 10 mg, for laboratory and research use only. Peptides are often supplied as salts, and PubChem also records a trifluoroacetate form of BPC-157, so documentation for a salt form can list a different formula and mass from the free-peptide values of C62H98N16O22 and 1419.5 g/mol.
The CAS number for BPC-157 is 137525-51-0, and its PubChem compound ID is 9941957. The same peptide appears in the literature under the codes PL 14736, PLD-116 and PL-10, and as bepecin, so searching under every name captures the full chemical literature.
BPC-157 is a Schedule 4 substance in the June 2026 Poisons Standard and is also listed in Appendix D, clause 5, which covers poisons that must not be possessed without authority. The TGA names it as an unapproved peptide product and says a research-use-only label does not make supply lawful. States and territories implement scheduling through their own legislation.
They are unrelated molecules. BPC-157 is a linear 15-residue peptide (GEPPPGKPADDAGLV, 1419.5 g/mol); TB-500 is a synthetic, N-acetylated seven-residue fragment of thymosin beta-4 (Ac-LKKTETQ, 889.0 g/mol). Their molar masses differ by about 530 g/mol, so mass spectrometry distinguishes them easily.
A chemical profile of BPC-157: the 15-residue sequence and its identifiers, salt forms, how identity is checked in the laboratory, storage, and its place in the Australian Poisons Standard.
A section-by-section guide to reading a peptide certificate of analysis: identity, HPLC purity, net peptide content, counter-ions, water, endotoxin, and the red flags that mean a COA does not check out.
How reverse-phase HPLC and mass spectrometry are used to test peptide purity and identity, how to read a chromatogram and a mass spectrum, and what each method cannot tell you.